Maternal RSV vaccine reduces infant RSV-associated hospitalizations by 80% through six months of life

Australia's RSV Maternal and Infant Protection Program is delivering strong protection for babies, with new research from The Kids Research Institute Australia showing RSV vaccination given during pregnancy reduces the risk of RSV-related hospitalization by more than 80% during an infant's first six months of life.

Read it at Medical Xpress ↗

← Front page